Apr 14, 2014 ... Southern District of California. DAO v. NATROL, INC., ET AL., C.A. No. 3:13!
02433 .... Fallon Trading Company, Inc., to transfer the following actions to the
United States District Court ... RIZZO v. KEURIG GREEN MOUNTAIN, INC., C.A.
No. 1:14!11030. - 7 - ..... MERCK & CO., INC., ET AL., C.A. No. 1:14!
Jun 8, 2016 ... National Grid Holdings, Inc., et al. v. ... Grid USA (NGUSA), and National Grid
USA Service Company, Inc. (NG Service) (collectively, ..... parties, and interviews
between them after the contract is executed,” citing Rizzo v. .... of such a right
does not, in all circumstances, mean shares are debts); Merck & Co. v.
Oct 5, 2015 ... In multivariate models, the main effect (auto-vs. allo-HCT) displayed a time-
varying effect .... In contrast, Vose et al. found grade 3 histology to be associated
with .... Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co,
Inc.; .... Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al.
May 14, 2012 ... 11-837. ) PUERTO RICO V. UNITED STATES, ET AL. ) 11-876 ... ET AL. 11-1117.
SCHNELLER, JAMES D. V. MERCK AND COMPANY, INC.
Feb 3, 2012 ... L.R. 245; Merck Frosst Canada & Co. v. Canada (Minister of Health), 2003 FC
1422 (CanLII); Rizzo & Rizzo Shoes Ltd. (Re), ... McDougall, 2008 SCC 53, [2008
] 3 S.C.R. 41; Société Gamma Inc. v. .... Bastarache, Michel, et al.
Feb 28, 2003 ... Louis G. NAVELLIER et al., Plaintiffs and Respondents, v. Kenneth G. SLETTEN
... Consumer Cause, Inc. (2002) 29 Cal.4th 53, 67. .... Rizzo, supra, at p. 65; e.g.
..... Plaintiffs contend, citing DuPont Merck Pharmaceutical Co. v.
Jul 28, 2014 ... Molina et al. in an early report described eight patients undergoing HCT with ....
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. ... Wisconsin;
Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman ...
of All Others Similarly Situated,. Plaintiff vs. PFIZER INC., et al.,. Defendants. ....
Lambert Company, LLC, Philadelphia County Court of Common Pleas, No. ..... 12
, which indicates that EMD Serono (a biopharmaceutical division of Merck) and
Pfizer's ..... J. Rizzo, “Advertising and Competition in the Ethical Pharmaceutical .....
These results support the use of myeloablative IV-BU vs TBI-based conditioning
.... Adjusted survival and RFS curves were generated based on the final Cox
model using the method of Zhang et al. ..... The Medical College of Wisconsin;
Merck & Co, Inc; Millennium: The Takeda Oncology .... Giralt S,; Ballen K,; Rizzo
D,; et al.
Dec 17, 2007 ... Correspondence: Dr JD Rizzo, Center for International Blood and ..... Crown JP,
Leyvraz S, Verrill M, Guillem V, Efremidis A, Garcia-Conde Bru J et al. .... Ligand
Pharmaceuticals Inc.; Medac GmbH Germany; Merck & Co.; ...